1. Neuroinflammation preceding primary central nervous system lymphoma (PCNSL) – Case reports and literature review
   Max Norrington et al, 2021, Journal of Clinical Neuroscience CrossRef
2. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions
   Matthew A. Tremblay et al, 2017, Journal of the Neurological Sciences CrossRef
3. Tumefactive demyelination: updated perspectives on diagnosis and management
   Pedro Sánchez et al, 2021, Expert Review of Neurotherapeutics CrossRef
4. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis
   Zheng XiaoHong et al, 2023, Neurological Sciences CrossRef
5. Inflammatory Demyelinating Lesions: True Sentinel Lesion or Immune-Mediated Response to Lymphoma?
   Tianming Qiu et al, 2021, World Neurosurgery CrossRef
6. Myelin oligodendrocyte glycoprotein antibody-associated disease preceding primary central nervous system lymphoma: causality or coincidence?
   Meng-Ting Cai et al, 2023, Neurological Sciences CrossRef
7. Spontaneous Tumor Regression of Intracranial Solitary Fibrous Tumor Originating From the Medulla Oblongata: A Case Report and Literature Review
   Junya Yamaguchi et al, 2019, World Neurosurgery CrossRef
8. A Review of Clinical and Imaging Findings in Tumefactive Demyelination
   Mariko Nakayama et al, 2021, American Journal of Roentgenology CrossRef
9. Primary diffuse large B‐cell lymphoma of the central nervous system with rapidly progressing lesions after dimethyl fumarate treatment, showing relapsing and remitting symptoms: A case report
   Yuki Kitazaki et al, 2022, Clinical and Experimental Neuroimmunology CrossRef
10. Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders
    Meredith C. Frederick et al, 2016, Current Neurology and Neuroscience Reports CrossRef
11. Tumefactive Demyelination in Multiple Sclerosis
    Meredith C. Frederick et al, 2018, Neuroinflammation CrossRef
12. Histopathological variation in the demyelinating sentinel lesion of primary central nervous system lymphoma
    Madan Bajagain et al, 2020, Surgical Neurology International CrossRef
13. Tumefactive demyelinating lesions of 15 patients: Clinico-radiological features, management and review of the literature.
    Pedro Sánchez et al, 2017, Journal of the Neurological Sciences CrossRef
14. B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma
    Rodrigo Javier et al, 2018, Diagnostic Pathology CrossRef
15. Could Cerebral Inflammatory Lesions be the Cellular Origin of Primary Central Nervous System Lymphoma?
    Jie Ma et al, 2024, Journal of Craniofacial Surgery CrossRef
16. Inflammatory Brain Lesions as Omen of Primary Central Nervous System Lymphoma: A Case Report and Literature Review
    Yeong Kim et al, 2021, Brain Sciences CrossRef